Clinical Trial Data
Some US policymakers want the FDA to disregard clinical-trial data from China, which would lengthen development timelines and raise costs.
관련 기사
2026-06-20Don’t restrict Chinese biotech
Some US policymakers want the FDA to disregard clinical-trial data from China, which would lengthen development timelines and raise costs.
2026-06-20 Don’t restrict Chinese biotech